Connect with us

Cannabis News

Idaho Medical Marijuana Campaign Has More Than 100,000 Signatures For Legalization Ballot Measure As Deadline Nears

Published

on

Supporters of A He proposed a medical cannabis ballot initiative in Idaho he said they have collected more than 100,000 signatures and are making a final push to qualify the proposal for the November general election ballot by April 30.

A group called the Idaho Natural Medicine Alliance hopes to legalize medical cannabis as a treatment option for Idahoans with debilitating illnesses such as cancer, post-traumatic stress disorder, AIDS, epilepsy, Crohn’s disease or Alzheimer’s disease.

Under Idaho law, cannabis means the same thing as marijuana, and the two terms are sometimes used interchangeably.

Currently, all forms of cannabis are illegal in Idaho, but recreational marijuana or medical cannabis is available in every state bordering Idaho except Wyoming.

Supporters said they want to legalize medical cannabis to give people with serious illnesses and chronic pain an alternative to opioid medications.

“Hundreds of people have emailed us about how they have PTSD or epilepsy and they’re driving across the border and illegally buying gummy bears because they want some dignity in their custody, in their state, but they can’t get it, and they’re still getting these things because they’re there and they’re available,” said Amanda Bomanise Wason of the initiative. “This framework includes a very strong regulatory, limited access and medical program.”

Opposition is leading the Republican-controlled Idaho Legislature, which is pushing a competitive marijuana measure on the November ballot and urging voters to reject the medical cannabis ballot initiative.

“Idaho’s Medical Cannabis Act is not guaranteed to the extent that it would effectively legalize the widespread recreational use of marijuana,” Idaho lawmakers warned in a resolution passed earlier this month.

Who’s behind Idaho’s medical cannabis ballot initiative?

Rob Cronin, a Sun Valley businessman who has opened several restaurants in Idaho and across the country, is president and treasurer of the Natural Medicine Alliance PAC.

In an interview last week, Cronin said his experience as a cancer survivor and his friendship with the late Dr. Dori Tunney, a physician and philanthropist, inspired him to push the medical cannabis ballot initiative.

Tunnery was diagnosed with glioblastoma and treated his pain with opioids, which led to severe side effects, reduced appetite and severe physical decline, Cronin and Watson said.

In treatment in California, where cannabis is legal, Tunney tried medical cannabis jelly and Cronin and Watson said his appetite and sleep returned to normal and his pain decreased.

Cronin and Watson said Tunney began advocating for the legalization of medical cannabis in Idaho in 2022, a push he continued until his death in 2024.

Cronin said she also experienced serious side effects when she used opioids after surgery after cancer treatment. Cronin said today he weighs 175 pounds, but his weight has dropped to 119 pounds due to nausea, loss of appetite and sleep loss caused by opioids.

“The pain was excruciating and I was hammering the Vicodin like it was going to go out of style,” Cronin said. “I can say in my head all day that I would choose an alternative to opioids over cannabis, because opioids put you on that funky roller coaster of, ‘Oh, I feel better. Oh, I’m depressed, and my life is bad. Oww, now I’m in pain. Another opioid. Oh, I’m depressed again and my life is bad.’ It really messes with your head.”

Cronin and Watson said they met while volunteering with Tunney to help cancer patients in Idaho. Cronin and Watson said they support the measure to try to finish Tunney’s job before the Idaho Legislature tries to further curtail the ability of voters to legalize medical cannabis in Idaho.

Watson said most of the funding for the initiative comes from an investment in Double Springs Ranch, owned by Tunney and her husband. The ranch is located in central Idaho and produces hemp and hemp fiber and raises Black Angus cattle.

What is a ballot initiative and what will it take to get medical cannabis on the November ballot?

In Idaho, a ballot initiative is a form of direct democracy in which Idaho voters—not the Idaho Legislature—vote on whether to pass a bill.

Organizers say they are taking the Idaho Medical Cannabis Act to voters as a ballot initiative because the Idaho Legislature has not taken action to legalize medical cannabis.

All states surrounding Idaho other than Wyoming offer medical cannabis, such as Utah, or recreational marijuana, such as Washington, Oregon, Montana, and Nevada.

To qualify for the November general election, organizers must collect signatures from 6 percent of registered voters statewide, or 70,725 valid signatures. In addition to the total gross, organizers must also collect signatures from 6 percent of registered voters in at least 18 of Idaho’s 35 legislative districts.

The period for verifying the signatures of the State will end on April 30.

“I would say we’re cautiously optimistic,” Watson said Friday. “Right now, we’re collecting thousands of signatures a day to make sure we cross that threshold every legislative session. There are some rural areas in Idaho where we’re working really hard to get that 6 percent. Right now, we’ve collected over 100,000 raw signatures.”

The Idaho Natural Medicine Alliance is using paid signature gatherers in an effort to qualify the initiative for election. The alliance pays $25 an hour plus incentives, Watson said.

If the initiative qualifies for the November general election, it would need a simple majority of votes to pass.

Why is the Idaho Legislature against cannabis?

If the Idaho Medical Cannabis Act makes it to the ballot, there would be marijuana-related questions on the November ballot.

The Idaho Legislature has already come out against medical cannabis and placed an amendment to the Idaho Constitution on the November ballot. If approved by a majority of voters, it would be House Resolution 4 make it so that only the Idaho Legislature, not the voters, can legalize marijuana or other narcotics.

“Too many legislatures in this nation have sat and waited for initiative after initiative to come after them until they finally get overwhelmed and pass the legislature,” Sen. Scott Grow, R-Eagle, said last year. “We are acting because that is our responsibility.”

In the 2025 legislative session, the Idaho Legislature and Gov. Brad Little (R) passed a law that creates a mandatory minimum fine of $300 for anyone convicted of simple possession of marijuana, the Idaho Capital Sun previously reported.

This year, the Idaho Legislature also passed Senate Resolution 127, which encourages Idaho voters to reject a medical cannabis ballot initiative.

In the resolution, lawmakers warn that legalizing marijuana and medical cannabis has created problems for other states and would increase the Idaho Department of Health and Welfare’s budget and costs at a time when state revenues are uncertain.

Idaho lawmakers have also complained that the requirements for obtaining a cannabis medical card would be so low that almost anyone would be able to obtain one.

“The 18 medical conditions to qualify for a cannabis license, including insomnia, anxiety and acute pain, are so broad that almost anyone can qualify,” Idaho lawmakers wrote.

On Thursday, Idaho Secretary of State officials said 10,232 signatures have been submitted so far, and the office has deemed 4,698 of those signatures valid.

How would Idaho’s Medical Cannabis Act work?

Here’s how Idaho’s Medical Cannabis Act would work for the November election if a majority of Idaho voters pass the act.

  • Idahoans would be able to apply for a renewable cannabis medical card by submitting medical records showing a significant or terminal health condition such as cancer, HIV/AIDS, epilepsy, Alzheimer’s, MS, post-traumatic stress disorder, chronic pain.
  • Meanwhile, the state would initially issue three medical cannabis production licenses statewide, allowing a licensee to grow, produce, distribute and sell medical cannabis to people with a valid Idaho cannabis license. When Idaho’s population increases by 650,000, additional production licenses could be issued, bringing the total to six in the state. The production license application process requires a valid Idaho hemp license in good standing, submission of an operational plan, background checks and the use of a supervising pharmacist.
  • This law allows each licensee to operate up to six retail locations, two facility locations, a fulfillment center, a warehouse, and a distribution center.
  • For individuals with an Idaho medical cannabis card, online ordering, delivery and pickup at distribution centers would be permitted.
  • Using medical cannabis in public and sharing medical cannabis with someone who does not have an Idaho cannabis card would be prohibited by law in Idaho. It would also be illegal to drive, operate a ship, operate aircraft, operate heavy machinery or drive a train under the influence of medical cannabis.

Continue Reading

Cannabis News

Redefining the standards of UK cannabis

Published

on

By

Dalgety Ltd has entered into a partnership with Curaleaf Laboratories to supply pharmaceutical grade cannabis medicines to the UK cannabis market. The arrangement combines Dalgety’s cultivation operations, which are certified to EU-GMP standards, with Curaleaf Laboratories’ pharmaceutical manufacturing and distribution capabilities. According to the companies, this creates a UK-based supply route that does not rely on imported cannabis flowers, as Dalgety cultivates its product in-house. Dalgety claims it was the first company in the UK to grow, manufacture and supply EU-GMP medical cannabis from a single site.

© Curaleaf Laboratories

The growing facility, which is more than 30,000 square feet, is located indoors and uses hydroponic growing methods along with automated lighting, irrigation, humidity and temperature control systems. The company reports that it uses AI-assisted environmental monitoring, which extends the traceability of batches to the final product and compares them to operating standards for air filtration systems. Post-harvest processing is said to follow EU-GMP protocols, including microbial and cannabinoid testing.

The stated goal of this approach is to reduce between-harvest variation in terms of THC and CBD content, terpene profiles, and microbial safety. Dalgety says his cultivation is overseen by staff with experience in horticulture and biochemistry, some of whom have worked on cannabis cultivation projects internationally.

Through a partnership with Curaleaf Laboratories, Dalgety’s UK-grown cannabis is processed and distributed through a UK-based supply chain, rather than imported from overseas. Companies suggest that this arrangement can shorten the time it takes to get products to market compared to importing, and reduce the likelihood of supply disruptions. Because Dalgety and Curaleaf Laboratories are involved in cultivation, manufacturing and distribution, the companies say this oversees the product at every stage, making it clearer for prescribers to see where and how the product was made.

© Curaleaf Laboratories

Dalgety operates to EU-GMP standards and has been subject to regulatory review by the MHRA and the Home Office. Its operations include environmental monitoring, microbial testing, stability testing, controlled drying and curing procedures and quality assurance processes, along with controlled and secure facilities.

The company describes its work as controlled environment farming, hydroponic systems, environmental control technology, and efforts to stabilize cannabis genetics and phenotypes for batch-to-batch consistency.

© Curaleaf Laboratories

Dalgety has also opened its cultivation facilities for visits to healthcare professionals, clinicians, pharmacists, researchers and other industry stakeholders. The company says this is in response to the fact that much of the cannabis historically supplied to UK patients has been grown overseas, which has limited opportunities for UK clinicians to see first-hand the cultivation and quality control processes. These tours aim to provide visitors with information on cultivation standards, EU-GMP compliance procedures, environmental control systems, testing processes and the regulatory framework governing cannabis manufacturing in the UK.

Dalgety and Curaleaf Laboratories describe their partnership as expanding access to UK-grown medical cannabis, improving supply chain reliability and helping to meet sector regulations, placing it in the wider context of growing demand for cannabis-based treatments from UK patients.

For more information:
Curaleaf Laboratories
Email: (email protected)
https://curaleaflaboratories.co.uk/

Continue Reading

Cannabis News

Arkansas GOP Governor And Democratic Challenger Agree On Opposing Marijuana Legalization

Published

on

By

“Giving more access to drugs, especially recreational access, does nothing to help or benefit Arkansans.”

Antoinette Grajeda, Arkansas attorney

Contains medical marijuana It generated more than $1 billion since Arkansas voters legalized it in 2016

After the state opened its first dispensary in 2019, thousands of Arkansans joined the program and spent a record $291.1 million on medical marijuana in 2025, according to the state Department of Finance and Administration.

Tax revenue from those sales now supports free breakfast for public school students after lawmakers passed legislation last year.

Medical marijuana programs have expanded across the country, as has recreational marijuana. Two dozen states, including neighboring Missouri, allow recreational marijuana use, according to state legislatures.

Arkansas voters rejected an effort to legalize recreational marijuana in 2022despite the national teams spending millions in support of the measure.

Restrictions on marijuana have been relaxed at the federal level, and the US Department of Justice earlier this year downgraded the drug classification of medicinal cannabis.

Here’s what Arkansas’ gubernatorial candidates — Democratic State Sen. Fred Love, Republican Gov. Sarah Huckabee Sanders and Libertarian Colt Shelby — have to say about legalizing recreational marijuana.

Democratic State Sen. Fred Love

Love said he opposes legalization during a debate at the Arkansas Press Association’s annual conference in June.

Sitting in a crosswalk at her daughter’s school, Love said “marijuana is all over” as the children exited their vehicles. When you grow up in a community where recreational marijuana is present, you see that it doesn’t always have a positive effect, he said.

“I don’t think it’s something I support,” Love said. “I’ve seen the long-term impact.”

While he doesn’t personally support it, Love said he would support legalizing recreational marijuana if Arkansans voted on it.

Libertarian Colt Shelby

Shelby said he’s for whatever Arkansans want, so he would support legalizing recreational marijuana if voters approve.

Shelby said the state’s elected officials have forgotten what matters most is what Arkansans want, which is why she’s running for office.

Although Shelby says she doesn’t smoke weed herself, she says almost everyone knows it and she has the meds.

“It brings a lot of good things, so I won’t say that I’m against it, but let the people decide”, he said in the debate in June.

Republican Governor Sarah Huckabee Sanders

Sanders did not participate in the June debate, but said in an emailed statement that he does not support the legalization of recreational marijuana.

“Giving more access to drugs, especially recreational access, does nothing to help or benefit Arkansans,” Sanders said.

Sanders vetoed a law passed by the Legislature last year dispensaries have been allowed to deliver orders via a delivery vehicle or drive-through window.

The governor signed into law in 2023 the bill protecting the rights for medical marijuana patients and caregivers to obtain a license to carry a concealed handgun.

In 2025, Sanders backed that uses medical marijuana revenue to support free breakfast for all public school students.

This story was first published by the Arkansas Advocate.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

Will the top World Cup expert in the fruit, vegetable, and horticulture sector come from Canada, the U.S. or Belgium?

Published

on

By






FreshPublishers 2026 World Cup Group Stage






The World Cup is coming to an end, with the third-place play-off between France and England on Saturday, and the final between Spain and Argentina the following day. It won’t be long until the grand winner of FreshPublishers’ first World Cup pool is revealed.

© Fresh Publishers

As previously reported, Slim Kooli from Courchesne Laros is the favorite to win the €1,000 prize. He has secured a comfortable lead over Nol Batist of North American Interstate Greenhouse Company, while buyer Bjorn Van Ryckeghem of Deprez Construct is currently in third place.

1 Sim School Spain 1–0 2–1 737 9716
2 Nol Batist France 2–1 1–1 674 9433
3 Bjorn Van Ryckeghem France 2–2 3–1 674 9264
4 Christian Anton Smedshaug England 1–2 1–2 659 9134
5 Perry Springintveld Spain 1–1 2–1 647 9105
6 Willem Tijssen Spain 2–0 2–1 710 9098
7 Hans Borsboom Spain 2–1 2–1 528 9058
8 Bart Triemstra Spain 2–1 2–1 737 9052
9 Youness Bensaid Spain 2–1 1–1 722 8954
10 Vijay Dijkstra Portugal 2–0 2–1 382 8953

However, there have been some surprises during the tournament, and bonus points must be added, so we will keep the suspense a little longer. On Monday we will find out who is the main World Cup announcer in the international fruit, vegetable and horticulture sector…



Publication date:













Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media